{ "items": [ "\n\n
\n \n\n \n \n \n \n Knee\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n12 September 2023
\n \n \n \nArthrofibrosis is the build-up of too much scar tissue (fibrosis) after an injury or surgery resulting in a stiffening of a joint and causing pain and disability. It\u2019s common following knee replacement for osteoarthritis where 1 in 4 affected patients require additional surgery to correct the fibrosis and restore motion in the knee joint.
\n \n\n \n \n\n \n\n \n \n \n \n CSM\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n11 September 2023
\n \n \n \nThe Planetary Health Informatics Lab led by Associate Professor Sara Khalid at NDORMS has announced that it is a winner of a Global Grand Challenges award \u2013 an initiative fostering innovation to solve pressing global health and development problems and funded by the Bill & Melinda Gates Foundation.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n \n \n Publication\n \n \n\n \n\n\n
\n \n\n \n4 September 2023
\n \n \n \nA new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient\u2019s genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n3 August 2023
\n \n \n \nResearch into the onset and progression of diseases affecting musculoskeletal soft tissues could be greatly advanced using novel 3D models say NDORMS researchers in a review published in The Lancet Rheumatology.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n14 July 2023
\n \n \n \nA collaborative team that responded to the monkeypox (Mpox) epidemic by rolling out a vaccination clinic in Oxford has received an award for delivery in the OUH Staff Recognition Awards.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n6 July 2023
\n \n \n \nThe UK\u2019s first Space Innovation Lab, dedicated to understanding the effect of space microgravity on the ageing process, opens at the Botnar Institute today.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n3 July 2023
\n \n \n \nHuw Colin-York has been awarded a fellowship from the Engineering and Physical Sciences Research Council (EPSRC) to develop synthetic biology tools to understand the immune response.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n3 July 2023
\n \n \n \nA new type of macrophages recently identified in atherosclerotic lesions could provide a missing link in understanding the inflammatory origins of the common yet fatal condition.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n27 June 2023
\n \n \n \nResearchers at the University of Oxford are looking for 2000 volunteers with psoriasis to join their study. Their goal is to explore any links between the skin condition and the development of arthritis.
\n \n\n \n \n\n \n\n \n \n \n \n Hip\n \n \n \n \n Main\n \n \n \n \n OCTRU\n \n \n \n \n Orthopaedics and trauma\n \n \n\n \n\n\n
\n \n\n \n22 June 2023
\n \n \n \nA large trial has found that using high-dose dual-antibiotic loaded cement is unlikely to reduce the risk of surgical site infection in people who have had a hip replacement.
\n \n\n \n \n\n \n\n \n \n \n \n Main\n \n \n \n \n Shoulder\n \n \n\n \n\n\n
\n \n\n \n22 June 2023
\n \n \n \nPatients treated by surgeons who average over 10 shoulder replacements a year have a lower risk of reoperation and serious complications, and a shorter hospital stay than those treated by surgeons who do fewer operations, finds a study published by The BMJ.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Main\n \n \n \n \n OCTRU\n \n \n \n \n Trauma\n \n \n\n \n\n\n
\n \n\n \n19 June 2023
\n \n \n \nA paper for the PATH-2 trial has received a gold award from the European Federation of National Associations of Orthopaedics and Traumatology (EFORT).
\n \n\n \n \n\n \n\n \n \n \n \n CSM\n \n \n \n \n Hip\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n9 June 2023
\n \n \n \nAn international group of researchers, including Prof. Daniel Prieto-Alhambra at NDORMS, have predicted that hip fracture burden will nearly double worldwide by 2050
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n1 June 2023
\n \n \n \nA team led by Alex Clarke at the Kennedy Institute has identified how high mitochondrial activity regulates antibody responses crucial for immunity but is also necessary for the development of lymphoma.
\n \n\n \n \n\n \n\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n23 May 2023
\n \n \n \nThe science behind the Ponseti method for treatment for clubfoot has been investigated in a new paper published in Royal Society Interface which explores how the tendon extracellular matrix reacts to being stretched.
\n \n\n \n \n\n \n\n \n \n \n \n Inflammation biology\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n17 May 2023
\n \n \n \nAbsci will apply its generative AI platform to The Kennedy Institute\u2019s immunology biorepository to speed the discovery and development of multiple therapies
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n10 May 2023
\n \n \n \nThe Kennedy professor is one of eight researchers from Oxford University who received a prestigious fellowship from the Royal Society in recognition of their work in the fields of science and medicine.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Main\n \n \n \n \n Statistics and epidemiology\n \n \n\n \n\n\n
\n \n\n \n3 May 2023
\n \n \n \nThe European Medicines Agency (EMA) initiative DARWIN EU\u00ae has completed its first studies and is calling for new data partners
\n \n\n \n \n\n \n\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n27 April 2023
\n \n \n \nClaire Edwards, Associate Professor of Bone Oncology, has been awarded the prestigious European Calcified Tissue Society (ECTS) Mike Horton preclinical/translational award in recognition of her significant contributions to the field of bone and calcified tissue.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n \n \n OACentre\n \n \n\n \n\n\n
\n \n\n \n21 April 2023
\n \n \n \nA recent study to test the feasibility of running a randomised controlled trial of hormone replacement therapy (HRT) for post-menopausal women with hand osteoarthritis, has produced positive results. The HOPE-e feasibility study paves the way for researchers to design a full trial.
\n \n\n \n \n